Metrohm acquires Innovative Photonic Solutions

1/14/2018 Photonic Solutions (IPS) from Monmouth Junction in New Jersey, USA, are pleased to announce the acquisition of IPS by Metrohm AG. The acquisition of IPS contributes to the strategic growth of Metrohm enhancing the company’s capabilities to further develop its portfolio of handheld Raman systems with industry leading solutions. A key element of this... Read more

908 Devices Launches Drug Hunter Mission Mode to Combat Fentanyl and High Priority Drugs

01.11.18 908 Devices, a pioneer of analytical devices for chemical and biomolecule analysis, today announced a new software update for MX908™, which includes the introduction of a new mission mode – Drug Hunter. This mode unlocks additional resolving power from the devices existing hardware to dramatically upgrade selectivity, which provides first responders with optimal detection and... Read more

Two Pore Guys and Maxim Integrated Announce Technology Collaboration and Investment

January 09, 2018 06:00 AM Pacific Standard Time SANTA CRUZ, Calif.–(BUSINESS WIRE)–Two Pore Guys (2PG) announced today that it is collaborating with Maxim Integrated Products, Inc. (NASDAQ: MXIM), on a series of analog signal processing technologies for 2PG’s solid-state nanopore diagnostic testing platform. As part of this collaboration, Maxim has invested in 2PG through its... Read more

With New PetroAlert® Well-Logging Gas Analyzer from MOCON-Baseline, Two Instruments Become One

MOCON Series 9200 PetroAlert Gas Analyzer   Tuesday, January 9, 2018 Media Contact: Gail Johnson, +1-720-414-7030, gail.johnson@ametek.com Technical Contact: Adam Gniewek, +1-860-572-1085, adam.gniewek@ametek.com LYONS, CO – Baseline, the industrial analyzer group within MOCON, Inc. and a leader in instruments used to test, measure and analyze gases, has introduced the latest addition to its PetroAlert® Series gas analyzers.... Read more

MGI Genetic Sequencer Certified in New 10x Genomics Compatible Program

–MGI’s BGISEQ-500RS Genetic Sequencer, Forthcoming MGISEQ Genetic Sequencers Compatible with 10x Genomics Solutions– PLEASANTON, CA. and SHENZHEN, CHINA —January 8, 2018—10x Genomics, Inc. and MGI, a subsidiary of BGI, today announced that the BGISEQ-500RS genetic sequencer has met the rigorous standards of the new 10x Genomics Compatible Program. MGI will also ensure that the MGISEQ... Read more

10x Genomics Announces Collaboration with Berry Genomics to Develop Next Generation Noninvasive Prenatal Testing (NIPT)

–Collaboration will be a new service offering for Berry Genomics and entry point for 10x Genomics into the NIPT Market in China– PLEASANTON, CA. and BEIJING, CHINA —January 8, 2018—10x Genomics, Inc., a company focused on accelerating genomic discovery, and Berry Genomics Co. Ltd (SZSE:000710), a company devoted to developing and offering genomic solutions for... Read more

Unchained Labs gives Lunatic a boost, nails high-end biologic quant!

January 8, 2018 – Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, amped up the protein quant range on Lunatic today, making measurements of up to 250 mg/mL IgG a cinch for biologics researchers. High-concentration biologics don’t have to be administered as often, plus patients... Read more

Seegene develops world’s first multiplex MDx assays with its AI system

Seoul, South Korea – Jan 3, 2018 – Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies headquartered in South Korea, announced today that, utilizing a newly created artificial intelligence (“AI”) based assay development system, the company succeeded in developing molecular diagnostics (“MDx”) assays in only four (4) days. These assays are high multiplex... Read more

BIO-TECHNE ACQUIRES ATLANTA BIOLOGICALS INC.

MINNEAPOLIS, Jan. 2, 2018 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) announced today that it has acquired all of the stock of Atlanta Biologicals, Inc. and its affiliated company, Scientific Ventures, Inc.. The transaction is financed through available cash on hand. Charles R. Kummeth, President and Chief Executive Officer of Bio-Techne, commented, “Atlanta Biologicals is a great... Read more